However, our findings from the OncoLnc database showed that high PANX1 expression may be associated with a poor prognosis in patients with KIRP, LUAD, PAAD, BLCA, BRCA, and CESC. This evidence concerns the gene PANX1 and pancreatic adenocarcinoma.